Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 380 participants.
Also called NCT05630586
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 380 participants
- Sponsor
- Registry
-
NCT05630586
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Recruiting
Technical summary
Registry record NCT05630586. Randomized; single masking; primary purpose treatment. Start 2023-04-12 (actual); primary completion 2025-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke
- Acronym
- ASSET
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Semaglutide
- Intervention (Other)
- Standard care
- Lead sponsor
- Aarhus University Hospital
- Collaborator
- Bispebjerg Hospital
- Collaborator
- Glostrup University Hospital, Copenhagen
- Collaborator
- Odense University Hospital
- Collaborator
- Herning Hospital
- Collaborator
- Aalborg University Hospital
- Collaborator
- Copenhagen University Hospital, Rigshospitalet
Record details
- Record id
cardio:ct-nct05630586- Content hash
699340d8b3a8dbac5258f8aeb71b3f2ce2b592556cbc565dfc74b805e9943b36